FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review

NEXT STORY
Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020
PREV STORY
BioXcel Therapeutics to Host Second Quarter 2020 Operating and Financial Results Conference Call and Webcast
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precipio Signs First Major International Services Contract

author_avatar
NASDAQ Market News

ViralClear adds St. David’s HealthCare in Austin, Texas, to its Planned Phase II trial for its Broad-Spectrum Oral Anti-Viral Candidate for COVID-19

author_avatar
NASDAQ Market News

Study published in Cancer Discovery Indicates that NY-ESO SPEAR T-cells are Long-lived, Self‑renewing, and Capable of Persistent Anti-Tumor Effects

Data indicate that self-renewing pools of SPEAR T-cells can produce a continuous supply of ...

author_avatar
NASDAQ Market News